TheraTech deal

THRT (Salt Lake City) acquired certain proprietary technologies and other assets of OraMed Inc., which develops controlled release oral drug delivery systems. THRT acquired a lozenge in preclinical research for buccal and sublingual delivery and an oral controlled release product in Phase II trials for an undisclosed indication. THRT acquired three patents, two issued and one allowed, covering applications for controlled oral delivery of pharmaceutical agents. ...